In May of 2012, CryoLife acquired Hemosphere, Inc. Hemosphere manufactures the HeRO® (Hemodialysis Reliable Outflow) Graft, which is a vascular access device for use in hemodialysis for patients with end-stage renal disease. The HeRO Graft is the ONLY fully subcutaneous AV access solution clinically proven to maintain long term access for hemodialysis patients with central venous stenosis.
| Website | http://www.herograft.com |
| Revenue | $2 million |
| Employees | 5 (4 on RocketReach) |
| Founded | 1998 |
| Address | 1655 Roberts Blvd., Kennesaw, Georgia 30144, US |
| Phone | +1 770-590-3753 |
| Technologies |
JavaScript
,
HTML
,
PHP
+32 more
(view full list)
|
| Industry | Medical Devices, Manufacturing General, Health Care, Manufacturing, Medical Device |
| Keywords | End Stage Renal Disease, Dialysis Access, Hemodialysis Access, Renal Failure Treatment, Dialysis Supplies, Kidney Disease Treatment, Vascular Access, Dialysis Solutions, Renal Care, Medical Technology, Patient Care, Blood Purification |
| Competitors | Organogenesis, MediWound Ltd., MiMedx, Aplion Medical Corp, Integra LifeSciences, Sientra, Inc., Bio-Tissue, SkinMedica Inc., An Allergan Company, Actavis plc (now Allergan), Acelity +39 more (view full list) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 62 Companies, NAICS Code 621 Companies |
Looking for a particular Hemosphere, Inc. employee's phone or email?
The Hemosphere, Inc. annual revenue was $2 million in 2026.
4 people are employed at Hemosphere, Inc..
Hemosphere, Inc. is based in Kennesaw, Georgia.
The NAICS codes for Hemosphere, Inc. are [62, 621].
The SIC codes for Hemosphere, Inc. are [384, 38].